DermTech Inc
NASDAQ:DMTK
DermTech Inc
Revenue
DermTech Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
DermTech Inc
NASDAQ:DMTK
|
Revenue
$15.3m
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
DermTech Inc
Revenue Breakdown
Breakdown by Geography
DermTech Inc
Breakdown by Segments
DermTech Inc
Total Revenue:
15.3m
USD
|
Test Revenue:
14.4m
USD
|
Smart Stickers:
592k
USD
|
Rna Extractions:
230k
USD
|
Project Management Fees:
90k
USD
|
See Also
What is DermTech Inc's Revenue?
Revenue
15.3m
USD
Based on the financial report for Dec 31, 2023, DermTech Inc's Revenue amounts to 15.3m USD.
What is DermTech Inc's Revenue growth rate?
Revenue CAGR 3Y
37%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for DermTech Inc have been 37% over the past three years .